image
Evoke Pharma, Inc. EVOK
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 3.11
7.49 %
$ 4.64 M
Market Cap
-1.17
P/E
BALANCE SHEET
17.5 M ASSETS
147.84%
Growth Rates
1Year 147.84%
3Years 18.33%
5Years 22.33%
7Years 11.97%
10Years 1.36%
10.5 M LIABILITIES
8.63%
Growth Rates
1Year 8.63%
3Years 14.30%
5Years 39.07%
7Years 8.88%
10Years 5.54%
7.04 EQUITY
272840148.43%
Growth Rates
1Year 272840148.43%
3Years 12456.43%
5Years 1642.55%
7Years 751.65%
10Years 287.63%
BALANCE SHEET DECOMPOSITION
Balance Sheet Evoke Pharma, Inc.
image
Current Assets 17.2 M
Cash & Short-Term Investments 13.6 M
Receivables 2.42 M
Other Current Assets 1.22 M
Non-Current Assets 281 K
Long-Term Investments 0
PP&E 154 K
Other Non-Current Assets 127 K
77.61 %13.82 %6.97 %Total Assets$17.5m
Current Liabilities 10.4 M
Accounts Payable 2.34 M
Short-Term Debt 5.06 M
Other Current Liabilities 2.98 M
Non-Current Liabilities 101 K
Long-Term Debt 101 K
Other Non-Current Liabilities 0
22.34 %48.27 %28.43 %Total Liabilities$10.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 13.6 4.7 9.8 9.1 8.1 5.7 5.3 7.7 9.0 8.7 14.2 24.2 0.1 0.9
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.4 0.7 0.6 0.3 23.3 K 0 0 0 0 0 0 0 0 0
Inventory 0.4 0.5 0.3 0.2 0.2 0 0 0 0 0 0 0 0 0
Other Current Assets 0.8 0.9 1.0 0.9 1.0 0.6 0.3 0.3 0.3 0.8 1.1 0.2 0 39.5 K
Total Current Assets 17.2 6.8 11.7 10.6 9.3 6.2 5.6 7.9 9.3 9.5 15.2 24.4 0.1 0.9
PP&E 0.2 0 0.1 12.4 K 0.1 0.1 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.1 0.2 (0.1) 12.4 K 11.6 K 11.6 K 11.6 K 11.6 K 11.6 K 8 K 53 K 0.6 0 0
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 17.5 7.1 11.9 10.6 9.4 6.4 5.7 7.9 9.3 9.5 15.3 25.0 0.1 0.9
LIABILITIES
Accounts Payable 2.3 1.7 0.9 0.9 1.3 1.0 0.5 1.0 0.5 0.9 1.0 0.3 96.8 K 0
Short Term Debt 5.1 5.0 0.3 24.9 K 0.2 0.3 0 0 0 0.1 0.2 1.4 0 0
Other Current Liabilities 3.0 2.9 0.5 0.5 6.0 0.7 1.2 1.0 0.9 0.8 0.7 0.6 0.5 0.3
Total Current Liabilities 10.4 9.6 1.7 1.4 7.5 2.0 1.6 2.1 1.4 1.8 1.9 2.3 0.6 0.3
Long Term Debt 0.1 5.0 5.0 5.0 5.0 0 0 0 0 4.2 4.2 1.5 1.0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 1.6 1.1 0.6 0.1 0 0 3.7 4.1 0 0 6.83 K 18.2 0
Total Liabilities 10.5 9.6 7.8 7.0 12.6 2.0 1.6 5.8 5.5 6.1 6.1 3.8 19.8 18.6
EQUITY
Common Stock 149 334 334 3.27 K 2.66 K 2.44 K 1.74 K 1.54 K 1.24 K 720 611 610 124 124
Retained Earnings (128 791 632.0) (123.4) (115.6) (107.4) (98.9) (85.7) (78.6) (71.0) (58.8) (48.1) (35.9) (22.7) (19.9) (17.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 0 (25.0) (18.2) 0
Total Equity 7 038 010.0 (2.6) 4.1 3.6 (3.2) 4.4 4.0 2.2 3.8 3.5 9.2 21.2 (19.7) (17.7)
Total Liabilities and Equity 17.5 7.1 11.9 10.6 9.4 6.4 5.7 7.9 9.3 9.5 15.3 25.0 0.1 0.9
SHARES OUTSTANDING
Common Shares Outstanding 1.4 0.3 0.3 0.2 0.2 0.2 0.1 0.1 64.8 K 45 K 41.9 K 16.4 K 8.61 K 7.9 K